Clinical Trial

Interest of Broadband Spectroscopy Analysis by Infrared Laser on Liquid Biopsies in Breast Cancer Screening

Study acronym: ICRG0101
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to validate the interest of broadband spectroscopy analysis (femto/attosecond by infrared laser) on liquid biopsies in breast cancer screening.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2020-02-14; most recent amendment 2025-09-03.
Status change: Recruiting → Active, Not Recruiting 2024-06-14
Status change: Not Yet Recruiting → Recruiting 2021-05-27
Trial Details
NCT Number NCT04273542
Lead Sponsor Centre Jean Perrin
Collaborators: International Cancer Research Group, United Arab Emirates
Conditions Breast Cancer Female, BRCA1 Mutation, BRCA2 Mutation
Enrollment 1,100 participants
Start Date 2021-05-31
Primary Completion 2029-05 (estimated)
Study Completion 2029-05 (estimated)
Updated on ClinicalTrials.gov 2025-09-10